Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Epidermal growth factor receptor")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4172

  • Page / 167
Export

Selection :

  • and

Translational research of a novel humanized epidermal growth factor receptor-related protein: a putative inhibitor of pan-ErbBFU, Xian-Hua; JUN LI; HUANG, Jian-Jin et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 6, pp 1373-1376, issn 0344-5704, 4 p.Article

Photochemical targeting of epidermal growth factor receptor: A mechanistic studySAVELLANO, Mark D; HASAN, Tayyaba.Clinical cancer research. 2005, Vol 11, Num 4, pp 1658-1668, issn 1078-0432, 11 p.Article

Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474ARAO, Tokuzo; FUKUMOTO, Hisao; TAKEDA, Masayuki et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 9101-9104, issn 0008-5472, 4 p.Article

Bronchioloalveolar carcinoma: A model for investigating the biology of epidermal growth factor receptor inhibitionGANDARA, David R; WEST, Howard; CHANSKY, Kari et al.Clinical cancer research. 2004, Vol 10, Num 12, pp 4205s-4209s, issn 1078-0432, 2Conference Paper

Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapyCHUA, Daniel T. T; NICHOLLS, John M; SHAM, Jonathan S. T et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 1, pp 11-20, issn 0360-3016, 10 p.Article

Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomasQUANG, Tony S; BRADY, Luther W.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 972-975, issn 0360-3016, 4 p.Conference Paper

Searching for reliable epidermal growth factor receptor response predictorsHARARI, Paul M; HUANG, Shyh-Min.Clinical cancer research. 2004, Vol 10, Num 2, pp 428-432, issn 1078-0432, 5 p.Article

Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFR) enhances the radiosensitization properties of anti-EGFR treatment in prostate cancer cellsBONNER, James A; BUCHSBAUM, Donald J; ROGERS, Buck E et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 950-958, issn 0360-3016, 9 p.Conference Paper

Epidermal growth factor receptor inhibitors in clinical developmentDANCEY, Janet.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 1003-1007, issn 0360-3016, 5 p.Conference Paper

Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiationBUCHSBAUM, Donald J; BONNER, James A; GRIZZLE, William E et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 4, pp 1180-1193, issn 0360-3016, 14 p.Article

Cutaneous adverse effects with HER1/EGFR-targeted agents : Is there a silver lining?PEREZ-SOLER, Roman; SALTZ, Leonard.Journal of clinical oncology. 2005, Vol 23, Num 22, pp 5235-5246, issn 0732-183X, 12 p.Article

Current and Emerging Targeted Therapies for Metastatic Breast CancerPEREZ, Edith A; SPANO, Jean-Philippe.Cancer. 2012, Vol 118, Num 12, pp 3014-3025, issn 0008-543X, 12 p.Article

Epidermal growth factor receptor changes during breast cancer metastasisFUCHS, Ilka B; SIEMER, Ildiko; BOHLER, Helmut et al.Anticancer research. 2006, Vol 26, Num 6B, pp 4397-4401, issn 0250-7005, 5 p.Article

Epidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma : Possible implications for targeted therapyJINBIAO SHANG; YONGJIE SHUI; LIMING SHENG et al.Oncology reports. 2008, Vol 19, Num 2, pp 435-440, issn 1021-335X, 6 p.Article

Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibodyFOON, Kenneth A; YANG, Xiao-Dong; THOMPSON, John A et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 984-990, issn 0360-3016, 7 p.Conference Paper

Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLCLANGER, Corey J.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 991-1002, issn 0360-3016, 12 p.Conference Paper

Epidermal Growth Factor Receptor in the Prawn Macrobrachium rosenbergii: Function and Putative Signaling CascadeSHARABI, Omri; VENTURA, Tomer; MANOR, Rivka et al.Endocrinology (Philadelphia). 2013, Vol 154, Num 9, pp 3188-3196, issn 0013-7227, 9 p.Article

Predictive and Prognostic Markers in Neuro-OncologyVAN DEN BENT, Martin J; KROS, Johan M.Journal of neuropathology and experimental neurology. 2007, Vol 66, Num 12, pp 1074-1081, issn 0022-3069, 8 p.Article

New approaches to enhance chemotherapy in SCCHNBOURHIS, J.Annals of oncology. 2005, Vol 16, pp vi20-vi24, issn 0923-7534, SUP6Conference Paper

Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3TAKAOKA, Munenori; HARADA, Hideki; ANDL, Claudia D et al.Cancer research (Baltimore). 2004, Vol 64, Num 21, pp 7711-7723, issn 0008-5472, 13 p.Article

N-Caffeoyltyramine arrests growth of U937 and Jurkat cells by inhibiting protein tyrosine phosphorylation and inducing caspase-3PARK, Jae B; SCHOENE, Norberta.Cancer letters. 2003, Vol 202, Num 2, pp 161-171, issn 0304-3835, 11 p.Article

Targeting epidermal growth factor receptor in tumors: From conventional monoclonal antibodies via heavy chain-only antibodies to nanobodiesALTINTAS, Isil; JAN KOK, Robbert; SCHIFFELERS, Raymond M et al.European journal of pharmaceutical sciences. 2012, Vol 45, Num 4, pp 399-407, issn 0928-0987, 9 p.Conference Paper

The biological properties of cetuximabVINCENZI, Bruno; SCHIAVON, Gaia; SILLETTA, Marianna et al.Critical reviews in oncology/hematology. 2008, Vol 68, Num 2, pp 93-106, issn 1040-8428, 14 p.Article

Y1068 phosphorylation is the most sensitive target of disulfonated tetraphenylporphyrin-based photodynamic therapy on epidermal growth factor receptorWEYERGANG, Anette; PAL KRISTIAN SELBO; BERG, Kristian et al.Biochemical pharmacology. 2007, Vol 74, Num 2, pp 226-235, issn 0006-2952, 10 p.Article

Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutationTAJA-CHAYEB, Lucia; CANDELARIA, Myrna; BROM, Rocio et al.Lung cancer. 2005, Vol 50, Num 2, pp 259-263, issn 0169-5002, 5 p.Article

  • Page / 167